Site updated at Wednesday, 22 June 2016

Living with Dementia

Alzheimer Treatment

India’s Piramal buys Bayer’s potential Alzheimer drug

Indian drugmaker Piramal Healthcare has agreed to buy a research and development portfolio from Bayer AG, the company said, in a deal that gives Piramal rights to florbetaben, a possible Alzheimer treatment.

Florbetaben, which is in the final stages of clinical trials, works by detecting symptoms in probable sufferers of Alzheimer’s, and is expected… India’s Piramal buys Bayer’s potential Alzheimer drug   

Going Home (A short film on Dementia)

synthetic tau fibrils1 - mmse1 - sleepiness1 - trouble sleeping1 - disease progression1 - alzheimer's population1 - coronary heart disease1 - amyloid hypothesis1 - early alzheimer's damage1 - alzheimer’s disease1 - increased dementia risk1 - gradual degeneration1 - circumscribed cerebral atrophy1 - harvard medical school1 - korsakoff amnesic syndrome1 - ataxia4 - electroencephalogram1 - epidemiology1 - exercise2 - benadryl1 - antipsychotics1 - inflammatory process1 - parkinson's disease risk1 - alzheimer treatment1 - quantitative structural neuroimaging1 - stages of atherosclerosis1 - non-familial parkinson's1 - dementia progression1 - alzheimer's markers1 - haldol1 -